Consequently, the aim of this study was to determine potential differences in systemic inflammation and proteolytic activity between non-T2D and T2D patients, and whether such changes are associated with elevated F-GLP-1 in T2D. This evidence concerns the gene GCG and type 2 diabetes mellitus.